NEW NAME EXPANDED INDICATION DIFFERENTIATED TECHNIQUE
NEW NAME EXPANDED INDICATION DIFFERENTIATED TECHNIQUE
NEW NAME EXPANDED INDICATION DIFFERENTIATED TECHNIQUE
NEW NAME EXPANDED INDICATION DIFFERENTIATED TECHNIQUE
NEW NAME EXPANDED INDICATION DIFFERENTIATED TECHNIQUE
NEW NAME EXPANDED INDICATION DIFFERENTIATED TECHNIQUE

RHA® Dynamic Volume

Restore volume loss and address contour deficiencies in the midface, and treat moderate to severe dynamic wrinkles and folds1

TEOXANE RHA Dynamic Volume

BEFORE

AFTER

Results that last up to 15 months in wrinkles and folds, and up to 12 months in midface*1

Patient was treated with 3.6 mL RHA® Dynamic Volume: 3.0 mL for nasolabial fold correction, and 0.6 mL in oral commissures. Images captured before and two weeks after treatment. Results may vary.

May be appropriate for patients who desire:

  • Correction of midface volume loss caused by age-related fat loss, rapid/extreme weight loss, and natural aging.
  • Correction for areas such as radial cheek lines or deep nasolabial folds1-3

*Clinical effectiveness and safety were demonstrated in a 15-month clinical trial for the treatment of moderate to severe nasolabial folds. Clinical effectiveness and safety were demonstrated in a 12-month clinical trial for the treatment of midface volume deficiency.1,4

Explore more results

RHA® Dynamic Volume

Indicated for injection into the subcutaneous to supraperiosteal layers for cheek augmentation and/or correction of age-related midface contour deficiencies, as well as the deep dermis to superficial subcutaneous tissue for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds, in adults aged 22 years or older.1